Annual Financials for Radius Health Inc.
Fiscal year is January-December. All values USD millions. |
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
Sales/Revenue
|
22.11M | 99.24M | 173.32M | 238.65M | 229.97M | |
Sales Growth |
- | 348.80% | 74.65% | 37.69% | -3.63% | |
Cost of Goods Sold (COGS) incl. D&A |
2.18M | 9.46M | 17.6M | 18.1M | 19.51M | |
COGS excluding D&A |
231,000 | 6.59M | 15.29M | 16.4M | 18.35M | |
Depreciation & Amortization Expense |
1.95M | 2.87M | 2.31M | 1.69M | 1.16M | |
Depreciation |
1.45M | 2.07M | 1.51M | 895,000 | 362,000 | |
Amortization of Intangibles |
500,000 | 799,000 | 798,000 | 798,000 | 798,000 | |
COGS Growth |
- | 333.50% | 86.01% | 2.85% | 7.82% | |
Gross Income |
19.93M | 89.78M | 155.72M | 220.55M | 210.46M | |
Gross Income Growth |
- | 350.48% | 73.45% | 41.63% | -4.57% | |
Gross Profit Margin |
- | - | - | - | 91.52% | NA |
|
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
SG&A Expense |
268.9M | 283.04M | 267.95M | 302.97M | 264.78M | |
Research & Development |
82.23M | 98.88M | 115.92M | 159.19M | 134.48M | |
Other SG&A |
186.68M | 184.16M | 152.03M | 143.78M | - | |
SGA Growth |
- | 5.26% | -5.33% | 13.07% | -12.61% | |
Other Operating Expense |
- | 10.8M | - | - | - | |
Unusual Expense |
- | - | - | - | (1.96M) | |
EBIT after Unusual Expense |
- | - | - | - | (52.36M) | |
Non Operating Income/Expense |
(192,000) | 59,000 | 242,000 | (212,000) | 361,000 | |
Non-Operating Interest Income |
3.23M | 5.62M | 3.93M | 1.4M | 75,000 | |
Equity in Affiliates (Pretax) |
- | - | - | - | - | |
Interest Expense |
8.3M | 22.96M | 24.94M | 27.98M | 18.26M | |
Interest Expense Growth |
- | 176.63% | 8.63% | 12.20% | -34.75% | |
Gross Interest Expense |
8.3M | 22.96M | 24.94M | 27.98M | 18.26M | |
Interest Capitalized |
- | - | - | - | - | |
Pretax Income |
(254.24M) | (221.34M) | (132.99M) | (109.21M) | (70.18M) | |
Pretax Income Growth |
- | 12.94% | 39.91% | 17.88% | 35.74% | |
Pretax Margin |
- | - | - | - | -30.51% | NA |
Income Tax |
- | - | - | - | - | |
Income Tax - Current Domestic |
- | - | - | - | - | |
Income Tax - Current Foreign |
- | - | - | - | - | |
Income Tax - Deferred Domestic |
- | - | - | - | - | |
Income Tax - Deferred Foreign |
- | - | - | - | - | |
Income Tax Credits |
- | - | - | - | - | |
Equity in Affiliates |
- | - | - | - | - | |
Other After Tax Income (Expense) |
- | - | - | - | - | |
Consolidated Net Income |
(254.24M) | (221.34M) | (132.99M) | (109.21M) | (70.18M) | |
Minority Interest Expense |
- | - | - | - | - | |
Net Income |
(254.24M) | (221.34M) | (132.99M) | (109.21M) | (70.18M) | |
Net Income Growth |
- | 12.94% | 39.91% | 17.88% | 35.74% | |
Net Margin Growth |
- | - | - | - | -30.51% | NA |
Extraordinaries & Discontinued Operations |
- | - | - | - | - | |
Extra Items & Gain/Loss Sale Of Assets |
- | - | - | - | - | |
Cumulative Effect - Accounting Chg |
- | - | - | - | - | |
Discontinued Operations |
- | - | - | - | - | |
Net Income After Extraordinaries |
(254.24M) | (221.34M) | (132.99M) | (109.21M) | (70.18M) | |
Preferred Dividends |
- | - | - | - | - | |
Net Income Available to Common |
(254.24M) | (221.34M) | (132.99M) | (109.21M) | (70.18M) | |
EPS (Basic) |
(5.80) | (4.88) | (2.89) | (2.35) | (1.49) | |
EPS (Basic) Growth |
- | 15.86% | 40.79% | 18.65% | 36.77% | |
Basic Shares Outstanding |
43.8M | 45.36M | 46.03M | 46.46M | 47.22M | |
EPS (Diluted) |
(5.80) | (4.88) | (2.89) | (2.35) | (1.49) | |
EPS (Diluted) Growth |
- | 15.86% | 40.79% | 18.65% | 36.77% | |
Diluted Shares Outstanding |
43.8M | 45.36M | 46.03M | 46.46M | 47.22M | |
EBITDA |
(247.02M) | (201.2M) | (109.92M) | (80.73M) | (53.16M) | |
EBITDA Growth |
- | 18.55% | 45.37% | 26.56% | 34.15% | |
EBITDA Margin |
- | - | - | - | -23.11% | NA |